SPT — AGM Information 2022

Jun 17, 2022

ScinoPharm Taiwan, Ltd. Notice of 2022 Annual General Shareholders’ Meeting (Summary Translation)

1. Shareholders are encouraged to exercise their voting rights through TDCC’s e-Voting service during the COVID-19 (Novel Coronavirus Disease 2019) pandemic. If shareholders intend to attend Shareholders’ Meeting, each shareholder shall put on a face mask at all times. Our staff will help to measure the body temperature at the entrance. If the temperature is higher than 37.5 ° C (forehead temperature) or 38 ° C (ear temperature), shareholders won’t be allowed to enter the meeting site.

2. In case that the meeting site is changed due to pandemic, please refer to the MOPS material information.

The 2022 Annual General Shareholders’ Meeting (the “Meeting”) of ScinoPharm Taiwan, Ltd. (the “Company”) will be convened at 10:00 a.m., Monday, May 30, 2022 at ScinoPharm Taiwan, Ltd. (1 Nan-Ke 8[th] Road, Southern Taiwan Science Park, Shan-Hua, Tainan, Taiwan).

1. The agenda for the Meeting is as follows:

2. I. Report Items

   • (1) 2021 Business Report.

   • (2) Audit Committee’s Review Report on 2021 Financial Results.

   • (3) 2021 Remuneration for Employees and Directors.

3. II. Ratification Items

   • (1) Ratification of 2021 Business Report and Financial Statements.

   • (2) Ratification of the Proposed Distribution of 2021 Earnings.

4. III. Discussion Items

   • (1) Proposed Amendments to the Articles of Incorporation of the Company.

   • (2) Proposed Amendments to the Operational Procedures for Loaning of Company Fund and Operational Procedures for Endorsements and Guarantees of the Company.

   • (3) Proposed Amendments to the Operational Procedures for Acquisition and Disposal of Assets of the Company.

   • (4) Proposed release the Directors (including Independent Directors) and their representatives from non-competition restrictions

5. IV. Extemporary motions

1

1. Proposal for distribution of 2021 profits has been resolved by the Board of Directors as follows:

2. Proposed cash dividend is $379,554,827, which is equivalent to $0.48 per share. Upon the approval of Annual General Shareholders’ Meeting, it is proposed that the Board of Directors be authorized to resolve the distribution record date.

3. Pursuant to Article 165 of the Company Act, the Company hereby closes the share transfer registration from April 1 2022 to May 30, 2022.

4. If any shareholder solicits for a proxy, the Company will disclose the summarization of the solicitation prepared by the Company on the website of the Securities and Futures Institute (http://free.sfi.org.tw) on April 29, 2022. If any investor wishes to make inquiries, please log into the “free inquiry system for published information of proxy” on the website, and click the right side “entrance to published information of proxy” and input the key words for the inquiry.

5. The shareholder’s voting power of this annual shareholders' meeting may be exercised by way of electronic transmission, and the exercising period will be from April 30, 2022 through May 27, 2022. Please log in the “Stockvote” established by Taiwan Depository & Clearing Corporation at http://www.stockvote.com.tw.

6. The institution for tallying and verifying proxy forms of 2022 general shareholders’ meeting is Stock Registration Department, President Securities Corporation.

7. If there exist any matters that shall be itemized in the causes and the essential contents thereof shall be explained pursuant to Article 172 of the Company Law, the essential contents can be found at the Market Observation Post System (http:// mops.twse.com.tw). Please log into said website, and click “electronic books”, key in the Year “2022,” select the code of the Company “1789,” and read references related to the shareholders’ meeting.

Board of Directors ScinoPharm Taiwan, Ltd.

2